Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Levocetirizine vs Cetirizine in SAR
NCT00291642Phase 2Completed
- Sponsor
- UCB
- Start
- Jan 2006
- Primary completion
- Apr 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of levocetirizine and cetirizine in seasonal allergic rhinitis (SAR) (5 arms), sponsored by UCB. Primary endpoint: Change From Baseline in the Major Symptom Complex (MSC) Score. Started Jan 2006; status: completed.
02
Drugs
levocetirizinecetirizine
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT00291642.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00291642.